Reflecting a prestigious Harvard Medical School, Dr. Foidart focuses on aggressive tumor types through a range of highly specialized research axes, while maintaining robust clinical practice in breast cancer and gastrointestinal tumors.

Academic Titles & Degrees:  MD and PhD (University of Liège); Graduate of the Global Clinical Scholars Research Training Program at Harvard Medical School.

Current Executive & Clinical Appointments:  Senior Medical Oncologist at CHU de Liège; Professor at the University of Liège Faculty of Medicine.

Research Axes & Leadership:

• Triple-negative breast cancer: Identification of therapeutic targets and the impact of whole-genome duplication.
• Pancreatic adenocarcinoma: Research into immune sensitization and radioligands.
• Immunotherapy Toxicity: Early detection of immunotherapy-related side effects.
• High-Impact Publications & Awards:   Nature Communications, Science Translational Medicine, Cancer Cell, PNAS, Clinical Cancer Research.